BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15611153)

  • 1. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst.
    Obrosova IG; Mabley JG; Zsengellér Z; Charniauskaya T; Abatan OI; Groves JT; Szabó C
    FASEB J; 2005 Mar; 19(3):401-3. PubMed ID: 15611153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.
    Drel VR; Pacher P; Vareniuk I; Pavlov I; Ilnytska O; Lyzogubov VV; Tibrewala J; Groves JT; Obrosova IG
    Eur J Pharmacol; 2007 Aug; 569(1-2):48-58. PubMed ID: 17644085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats.
    Obrosova IG; Drel VR; Oltman CL; Mashtalir N; Tibrewala J; Groves JT; Yorek MA
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1645-55. PubMed ID: 17911342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.
    Vareniuk I; Pavlov IA; Drel VR; Lyzogubov VV; Ilnytska O; Bell SR; Tibrewala J; Groves JT; Obrosova IG
    Exp Neurol; 2007 Jun; 205(2):425-36. PubMed ID: 17475250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.
    Drel VR; Pacher P; Vareniuk I; Pavlov IA; Ilnytska O; Lyzogubov VV; Bell SR; Groves JT; Obrosova IG
    Int J Mol Med; 2007 Dec; 20(6):783-92. PubMed ID: 17982684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
    Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
    Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
    Negi G; Kumar A; Sharma SS
    Biochem Biophys Res Commun; 2010 Jan; 391(1):102-6. PubMed ID: 19900402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats.
    Sugawara R; Hikichi T; Kitaya N; Mori F; Nagaoka T; Yoshida A; Szabo C
    Curr Eye Res; 2004 Jul; 29(1):11-6. PubMed ID: 15370362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy.
    Arora M; Kumar A; Kaundal RK; Sharma SS
    Eur J Pharmacol; 2008 Oct; 596(1-3):77-83. PubMed ID: 18768138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst.
    Szabó C; Mabley JG; Moeller SM; Shimanovich R; Pacher P; Virag L; Soriano FG; Van Duzer JH; Williams W; Salzman AL; Groves JT
    Mol Med; 2002 Oct; 8(10):571-80. PubMed ID: 12477967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.
    Stavniichuk R; Shevalye H; Lupachyk S; Obrosov A; Groves JT; Obrosova IG; Yorek MA
    Diabetes Metab Res Rev; 2014 Nov; 30(8):669-78. PubMed ID: 24687457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.
    Vareniuk I; Pavlov IA; Obrosova IG
    Diabetologia; 2008 Nov; 51(11):2126-33. PubMed ID: 18802679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
    Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.
    Vareniuk I; Pacher P; Pavlov IA; Drel VR; Obrosova IG
    Int J Mol Med; 2009 May; 23(5):571-80. PubMed ID: 19360314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.
    Stavniichuk R; Drel VR; Shevalye H; Maksimchyk Y; Kuchmerovska TM; Nadler JL; Obrosova IG
    Exp Neurol; 2011 Jul; 230(1):106-13. PubMed ID: 21515260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.
    Ilnytska O; Lyzogubov VV; Stevens MJ; Drel VR; Mashtalir N; Pacher P; Yorek MA; Obrosova IG
    Diabetes; 2006 Jun; 55(6):1686-94. PubMed ID: 16731831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of neurobehavioral and neurochemical alterations in STZ-induced diabetic rats by FeTMPyP, a peroxynitrite decomposition catalyst and 1,5-Isoquinolinediol a poly(ADP-ribose) polymerase inhibitor.
    Jangra A; Datusalia AK; Sharma SS
    Neurol Res; 2014 Jul; 36(7):619-26. PubMed ID: 24620961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction.
    Pacher P; Liaudet L; Bai P; Mabley JG; Kaminski PM; Virág L; Deb A; Szabó E; Ungvári Z; Wolin MS; Groves JT; Szabó C
    Circulation; 2003 Feb; 107(6):896-904. PubMed ID: 12591762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction.
    Radovits T; Seres L; Gero D; Lin LN; Beller CJ; Chen SH; Zotkina J; Berger I; Groves JT; Szabó C; Szabó G
    Mech Ageing Dev; 2007 Feb; 128(2):173-81. PubMed ID: 17116320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.
    Obrosova IG; Li F; Abatan OI; Forsell MA; Komjáti K; Pacher P; Szabó C; Stevens MJ
    Diabetes; 2004 Mar; 53(3):711-20. PubMed ID: 14988256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.